News brief­ing: Tri­al soft­ware firm ERT merges with imag­ing com­pa­ny Bio­clin­i­ca; Ab­Cellera bumps IPO range

ERT, an en­ter­prise soft­ware and con­sult­ing firm that sells plat­forms to run el­e­ments of clin­i­cal tri­als, has bought a new com­pa­ny in or­der to boost its imag­ing ca­pa­bil­i­ties.

The busi­ness is ac­quir­ing Bio­clin­i­ca for an undis­closed sum, giv­ing ERT, or eRe­searchTech­nol­o­gy, what it says is the most com­pre­hen­sive end­point da­ta col­lec­tion port­fo­lio. With Bio­clin­i­ca’s imag­ing tech­nol­o­gy in the fold, ERT can fur­ther fo­cus on its da­ta an­a­lyt­ics, vir­tu­al pa­tient vis­its and hy­brid tech­no­log­i­cal pro­grams, among oth­er things.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER